Main page content

Displaying results 1 - 5 of 5
Publication ID: PEP21-06-01-003
Published:

This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.

Publication ID: PEP21-02-01-002
Published:

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

Publication ID: PEP20-03-01-002
Published:

A brochure for parents and caregivers about the risks associated with misusing prescription pain medications for teens and the importance of having conversations with their children to help them avoid taking medication that is not theirs.

Publication ID: SMA12-4677B2
Published:

Not worth the risk. Even if it's legal. 

This brochure describes for teens the dangers of misusing prescription drugs and over-the-counter drugs. It lists warning signs of prescription drug misuse, and offers advice on receiving help.

Publication ID: SMA12-4676B1
Published:

This brochure gives practical advice to parents talking with teens about the dangers of prescription drug misuse, highlighting symptoms and risks.